EFFECT OF A NEW TRIPLE SINGLE-PILL COMBINATION ON ORTHOSTATIC HYPOTENSION AND SYMPTOMATIC HYPOTENSION
Tian Wang, Amy Carroll, Stephen van der Hoorn, Sonali Gnanenthiran et autres
Objective: We evaluated the effect of GMRx2 (US tradename WIDAPLIKTM), a single pill triple combination (SPC) of telmisartan (T), amlodipine (A) and indapamide (I) on orthostatic and symptomatic hypotension, compared with placebo and dual blood pressure (BP) therapies, in patients with hypertension. …
au (code pays fourni par la source)
0 citations
Journal of Hypertension